In the mid-1970s, researchers found a new way they could use BCG bacteria in medical treatment. They found that if they injected live BCG in a liquid solution into the bladder, it helped prevent ...

BCG is a type of live but weakened bacteria that stimulates your immune system to attack bladder cancer cells. The drug is made from a strain of the same bacteria used in the tuberculosis vaccine.

What is BCG? BCG is a vaccine for tuberculosis (TB). It is also helps to stop or delay bladder cancers growing back or spreading into the deeper layers of the bladder. The vaccine contains a weakened ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

The new study maps BCG's broader effects outside the bladder. Previous research had shown that when given as a vaccine, BCG bacteria raise the body's general defenses against a variety of other ...

The team showed that when BCG was administered to mice in their bladders, the bacteria traveled to their bone marrow — and could actually be cultured directly from it. And it is in the bone marrow, ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

The team showed that when BCG was administered to mice in their bladders, the bacteria traveled to their bone marrow — and could actually be cultured directly from it.

These bacteria may cause food poisoning in one form, ... When one hears the word Salmonella, the immediate association might be food poisoning, or even eggs; for BCG vaccine, ...

When BCG became available in 1976, it was considered a breakthrough strategy. First used as a tuberculosis vaccine, it contains a weakened bacteria that triggers the immune system to fight the cancer.

Supply shortages of TICE BCG in the U.S. have become a significant impediment to the treatment of bladder cancer patients. In a recent Sermo survey of 100 U.S. urologists, 57 percent indicated ...